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ORIGINAL ARTICLE
Spinal Progenitor-Laden Bridges Support Earlier Axon
Regeneration Following Spinal Cord Injury
Courtney M. Dumont, PhD,1 Mary K. Munsell,1 Mitchell A. Carlson, MS,1 Brian J. Cummings, PhD,2–5
Aileen J. Anderson, PhD,2–5 and Lonnie D. Shea, PhD1,6
Following spinal cord injury (SCI), function is lost below the level of injury due to axon damage and demy-
elination. Spinal progenitors, and more broadly neural stem cells, can promote the growth of axons through
multiple mechanisms, yet their poor survival following transplantation has been limiting the ability to obtain
functional effects. In this study, we investigated multichannel poly(lactide-co-glycolide) bridges, which reduce
inflammation and promote axon regrowth, as a support for spinal progenitor survival and function at the injury
epicenter. Specifically, we hypothesized that mouse embryonic day 14 (E14) spinal progenitors expressing
enhanced green fluorescent protein (EGFP) would lead to regenerative gains compared to age-matched adult
progenitor controls, which are expected to have similar regenerative capacity to the endogenous progenitors.
E14spinal EGFP progenitors were transplanted into a lateral T9-10 hemisection and EGFP+ cells were evident
in the bridge and contralateral tissue 8 weeks postinjury, with enhanced survival of E14 compared to adult
transplants. Only E14 progenitor-loaded bridges increased axon regrowth compared to blank bridges, resulting
in a 3.3-fold increase in axon density (1674 v 497 axons/mm2) and 3.6-fold increase in myelination (*30% of
axons) after 8 weeks. By 6 months, NeuN+ neural bodies were increased within the bridge region of mice
transplanted with E14 progenitors. Mice receiving E14 transplants exhibited modest improvements in loco-
motion, including an earlier ability to perform ipsilateral stepping. The combination of bridges with E14
progenitors produced synergistic reparative gains, with early axon growth and remyelination followed by latent
increases in neural bodies within the bridge.
Keywords: spinal progenitor cells, spinal cord injury, biomaterial, axon elongation
Impact Statement
Spinal cord injury (SCI) results in loss of tissue innervation below the injury. Spinal progenitors have a greater ability to
repair the damage and can be injected into the injury, but their regenerative potential is hampered by their poor survival after
transplantation. Biomaterials can create a cell delivery platform and generate a more hospitable microenvironment for the
progenitors within the injury. In this work, polymeric bridges are used to deliver embryonic spinal progenitors to the injury,
resulting in increased progenitor survival and subsequent regeneration and functional recovery, thus demonstrating the
importance of combined therapeutic approaches for SCI.
Introduction
Spinal cord injury (SCI) results in primary nervedamage, in addition to axonal dieback and de-myelination
that ensue after the initial injury. Axon regrowth and myeli-
nation into and through the injury are necessary for re-
storing functional deficits; however, there are several
challenges to regeneration. Infiltrating immune cells and
astrocytes, as well as the presence of excitotoxic factors
and myelin debris contribute to the highly inflammatory
milieu and glial scar formation that present obstacles to
nerve regeneration.1,2 Delivery of a number of neuro-
trophic and anti-inflammatory factors is needed to over-
come these barriers to regeneration with transplanted cells
providing one potential source of exogenous factors to
regulate the biochemical milieu.3–6
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Neural stem cells (NSCs) actively promote nerve regener-
ation through a variety of mechanisms, including release of
neurotrophic factors, repopulation of beneficial neurons and
oligodendrocytes, and immune cell modulation. Numerous
growth factors,7–11 extracellular matrix proteins,12–16 and
proteoglycans13,15,17–22 are released by NSCs in vitro, with
observable increases in these factors in the tissue following
delivery of NSCs to a central nervous system (CNS) injury
site.4,6,23–25 While NSCs offer numerous proneurogenic ad-
vantages, a number of caveats associated with using NSCs
currently limit their efficacy. Careful selection of the NSC
source is required, as NSCs can be used to broadly define a
number of neural stem and progenitor populations that have
different neurogenic potentials.26 While it is widely accepted
that NSCs within the adult brain maintain some degree of
neurogenic potential,27,28 it is highly contentious whether adult
spinal progenitors are capable of forming new neurons
following injury.29–31 To that end, we will refer to trans-
planted cells within our studies as neural or spinal progen-
itors to denote the combined stem and progenitor population
within the embryonic spinal cord, while primarily progen-
itor cells are present within the adult spinal cord. Cell
source, including the age, tissue location, and species used
for isolation, as well as the ex vivo expansion techniques
employed to generate sufficient cells for transplantation will
also influence survival and the subsequent regenerative
potential of the transplants.26,32 Generally, neural stem and
progenitor survival without co-delivery of other pharma-
cological or biochemical factors have been reported as high
as 12% in mice based on bioluminescence assessment,33 but
is typically less than 0.5–2% when quantifying through flow
cytometry or histology, if quantified at all.26,34–36 Cell
survival as high as 5% has been reported following SCI
transplant; however, this study failed to discern between
exogenous transplants and infiltrating endogenous progen-
itors.37 Typically, poor survival is attributed to the shear
forces exerted on cells during the initial injection, if appli-
cable, and to the highly cytotoxic milieu,38,39 as most of the
cells die within the first few days after transplantation.
The method of delivery for cell transplants may affect sur-
vival, as most methods deliver the cells through direct injec-
tion. Direct injection of cells into a highly inflammatory injury
epicenter results in a further 50% reduction in survival of
transplanted cells,40 and increasing the dose of neural pro-
genitor cells does not result in a commensurate increase in
survival and proliferation.41 Increased neural progenitor cell
delivery to compensate for transplant death would require
more delivery sites rostral and caudal to the injury. Alter-
natively, utilizing prenatal or embryonic progenitor popula-
tions may have greater survival and subsequent regenerative
potential than postnatal or adult progenitors due to the in-
creased immunomodulatory capabilities of younger cells upon
both the innate and adaptive immunity.10,11,36,38 Coupling this
technique with a biomaterial as a platform for cell delivery
could provide a substrate for cell attachment, leading to an
upregulation of b1integrins triggering the MAPK signaling
that leads to activation of downstream survival and prolifera-
tion pathways.12,42 Activation of cell adhesion pathways has
long been reported to result in enhanced transplant survival39;
thus, early attachment of spinal progenitors to substrates offers
great promise. Biomaterial delivery of spinal progenitors may
also be beneficial to cell survival and subsequent engraftment
as these materials limit inflammation and scarring following
SCI by filling the injury and preventing cavity formation.
Biomaterial platforms such as soft hydrogels and highly
organized bridges have been evaluated for progenitor cell
delivery following SCI. Hydrogels can conform to the shape
of the injury site to promote regeneration and limit scar
formation after SCI.35,43,44 Current hydrogel technologies
offer a vehicle to deliver progenitors in high doses; how-
ever, most hydrogels employed in spinal cord repair lack
topographical cues to guide axon extension. Neural pro-
genitors within hydrogels are typically injected directly into
the injury, at which point the hydrogel will polymerize or
crosslink. During this process, the cells undergo shear
stresses that can reduce survival similar to direct injection
methods. Cell survival may also be limited by insufficient
time to spread and proliferate within the hydrogel as more
stable integrin binding reduces apoptosis and increases
survival by inhibiting the Rho/ROCK pathway after trans-
plantation.45 It is likely these factors contributed to the low
survival (1.2%) reported following injections of hyaluronan-
based hydrogels.35
Alternatively, bridges can be used to fill the gap between
the tissue rostral and caudal to the injury, limit scar forma-
tion, and readily guide axons extending through the injury
site.46–51 As the shape of a bridge would be predetermined,
spinal progenitors can be cultured on these substrates in ad-
vance, allowing the cells to spread throughout the material,
thus permitting them to acclimate to the substrate before
exposure to the elevated levels of inflammatory cytokines
after SCI. Poly(lactide-co-glycolide) (PLG) bridges have
been a promising biomaterial platform with limited scar
formation and guidance of axon elongation through the
injury.46,47,52,53 The high degree of porosity within these
bridges also allows for cell infiltration and integration of the
biomaterial with the surrounding tissue. Increased surface
area through porosity and channel design readily facilitates
delivery of therapeutic factors,54,55 such as spinal progenitors
that can enhance the regenerative potential of unmodified
bridges. Moreover, a bridge used as a progenitor delivery
system would result in viable transplanted cells directly in the
injury epicenter. While many bridge materials have been
able to control stem and progenitor proliferation and dif-
ferentiation in vitro, few have been employed to deliver
these cells following SCI.56–58
In this work, we hypothesize that embryonic day 14 (E14)
mouse spinal progenitors would promote increased regener-
ation after a lateral hemisection injury in the mouse spinal
cord when delivered on PLG bridges, with regeneration by
the E14 spinal progenitors surpassing age-matched (adult)
mouse spinal progenitor controls that are representative of the
endogenous progenitors that would traffic to the injury.
Spinal progenitors have been shown to elicit less of an im-
mune response than terminally differentiated cells due to low
antigen expression.38,59 The PLG bridges have also been
shown to attenuate the immune response46,60 and, in this
work, we evaluate whether the E14 spinal progenitors would
further alter immune cell infiltration into the bridge, resulting
in greater spinal progenitor transplant survival. To investigate
this potential immunomodulatory synergy, immunosuppres-
sants that would reduce inflammation were not used in this
study. We did not evaluate glial scar formation, as previous
reports have demonstrated that bridge implants, but not the
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progenitor cells, alter scar formation.53,61,62 A complemen-
tary increase in regeneration is expected in the event of in-
creased E14 progenitor survival within the bridge, as more
proneurogenic cells would be in the injury. Synergistic re-
generative improvements due to the presence of E14 spinal
progenitors in the bridges were evaluated in the context of
neuron and oligodendrocyte repopulation, axon growth and
myelination, and ipsilateral hindlimb stepping. Combining
bridges that mimic the architecture of the spinal cord with
proneurogenic E14 spinal progenitors delivered to the injury
epicenter was thought to lead to regenerative gains.
Materials and Methods
Multichannel bridge fabrication
Multichannel bridges with 90% porosity were generated
with final dimensions of 2.25 · 0.75· 1.25mm for use in
mouse spinal cord hemisection lesion as previously de-
scribed.47 Briefly, sugar strands drawn from caramelized
sucrose (Sigma, St. Louis, MO), dextran (Sigma), and glu-
cose (Sigma) were coated with a 1:1 mixture of PLG
microspheres (75:25 ratio of D,L-lactide to L-glycolide,
inherent viscosity 0.76 dL g-1; Lakeshore Biomaterials,
Birmingham, AL) and NaCl with an average granule size of
63–106 mm. Sugar strands were packed into a mold, equil-
ibrated to 800 psi of CO2 for 16 h, and subsequently released
at 60 psi/min to foam into the final structure. The bridges
were cut to size leached in distilled water, dried, and stored
in a desiccator at room temperature until sterilized. Im-
mediately before loading with cells or implantation into the
injury site, the bridges were rehydrated in water and then
disinfected with 70% ethanol for 2min. Bridges were then
rinsed in water and blotted twice on sterile filter paper to
remove excess water.
Spinal progenitor isolation
Adult and embryonic spinal progenitors were isolated
from the spinal cords of C57BL/6-Tg(CAG-EGFP)10sb/J
mice ( Jackson Laboratory, Bar Harbor, ME), enzymatically
dissociated into single cells, and expanded as neurospheres
in ultralow attachment flasks (Corning, Corning, NY). For
adult spinal progenitors, the spinal cord was isolated from
6- to 8-week-old female mice. Spinal cords were dissociated
with 1U/mL liberase (Roche, Basel, Switzerland) in Hank’s
balanced salt solution (Gibco, Carlsbad, CA) for 30min,
triturated, and centrifuged in an 4-morpholinepropane-
sulfonic acid:Opti-prep gradient (Sigma) to remove myelin.
Adult spinal progenitors were expanded in Dulbecco’s
Modified Eagle Medium (DMEM; Gibco) mixed 1:1 with
F12 medium supplemented with 1X B27(Gibco), 1X N2
(Gibco), 100mg/mL heparin (Sigma), and 20 ng/mL basic
fibroblast growth factor (FGF2; Peprotech, Rocky Hill, NJ)
and epidermal growth factor (Peprotech). Adult cell colonies
were passaged with liberase as needed and not used beyond
the second passage. For embryonic spinal progenitors, spinal
cords were isolated from E14 mouse pups and dissociated
with 10U/mL papain (Worthington, Lakewood, NJ), 37mg/
mL DNase (Sigma), and N-acetyl cysteine (NAC; Sigma) in
DMEM for 20min. E14 tissue was then triturated and
centrifuged, and E14 progenitors were expanded in DMEM
supplemented with 1X B27, 1X N2, 1X NAC, and 20 ng/mL
of FGF-2, and leukemia inhibitory factor (Peprotech). E14
cell colonies were passaged with papain as needed and not
used beyond the second passage.
Loading of bridges with progenitors
Neurospheres were collected, dissociated with 10U/mL
papain for 10min in thermomixer (Thermo Scientific,
Waltham, MA) at 1400 rpm at 37C, and centrifuged for
5min at 300g. Dissociated progenitors were resuspended at
1.25e5 cells/mL in fibrin solution [2mg/mL fibrinogen
(Millipore, Darmstadt, Germany), 5U/mL thrombin (Sig-
ma), and 2.5mM CaCl2 in 1 · tris buffered saline (Sigma)].
Fibrin was used as it provides an initial substrate for at-
tachment on the PLG bridges during the initial culture
phase, is biocompatible, and has been used extensively for
stem and progenitor cell transplantation.63,64 Cell-laden fi-
brin solution was pipetted onto bridges that had been dis-
infected in 70% ethanol. Bridges were semiwet, thus
allowing for the cell solution to be drawn into the pores as
described previously with lentiviral loading onto the PLG
bridges.53,65 Fibrin was polymerized for 5min at 37C and
then the culture medium was added as described in
Figure 1A. Loading of the 2.5 e5 enhanced green fluorescent
protein (EGFP)+ progenitors onto the bridge was confirmed
using an Axiovert LED fluorescent microscope (Zeiss,
Oberkochen, Germany) with 5 · dry objective. The medium
was supplemented with appropriate growth factors on day 2.
After 3 days of culture on the bridge, the cell-laden bridges
were implanted into a mouse hemisection injury or evalu-
ated with flow cytometry.
Flow cytometry
Neurospheres or spinal progenitor-loaded bridges were
dissociated into a single cell suspension with 1U/mL lib-
erase at 37C for 6min at 1400 RPM. Live cells were de-
tected with a violet fix exclusion dye, after which cells were
fixed with 4% paraformaldehyde and permeabilized. Cells
were stained with mouse anti-Nestin (1:200; Millipore) and
rabbit anti-OLIG2 (1:500; Millipore) for 30min at 4C,
rinsed, and incubated for 30min with species-specific sec-
ondary antibodies. Cells were analyzed on a Cyan5 flow
cytometer using appropriate excitation lasers and emission
filters (Beckman Coulter, Brea, CA). Data were analyzed
with FlowJo software (FlowJo, Ashland, OR).
Transplantation of progenitor cells
All animal work was performed with prior approval and
in accordance with the Animal Care and use Committee
guidelines at the University of Michigan. A T9–10 lateral
hemisection SCI was created in adult C57BL/6J female
mice 6–8 weeks of age, as previously described.47,53,65
Briefly, mice were anesthetized with 2% isoflurane and
provided preemptive pain management (1mg/kg bupiva-
caine). After confirmation of sufficient anesthesia, a 2 cm
incision was made in the skin between the scapula. A la-
minectomy was performed between T9–10 with a 2mm
lateral hemisection excised. Blank or cell-laden (E14 or
adult) bridges were implanted into the injury site. Injury site
was secured with gelfoam and then the muscles were su-
tured and skin stapled. Mice were immediately provided
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postoperative antibiotics (enrofloxacin 2.5mg/kg once a day
for 2 weeks), analgesics (buprenorphine 0.1mg/kg twice a
day for 3 days), and supportive care (saline 1mL/20 g once a
day for 5 days). Bladders were expressed twice daily until
function recovered and staples were removed after 10 days.
Mice were euthanized and spinal cord segments (T8–11)
were collected after 1, 8, or 24 weeks.
Immunohistochemistry analysis
Isolated spinal cords were flash frozen and then cryo-
sectioned transversely in 18 mm sections. Sections were
used throughout the length of the bridge for analysis, with
care taken to use tissues from the rostral, middle, and
caudal regions of the injury site (approximately three
sections 0.75mm in length), as indicated for each figure.
Samples were fixed, permeabilized as necessary, and in-
cubated for 4 h in 0.3% wt/vol Sudan Black (ACROS,
Geel, Belgium) in 70% ethanol to reduce background au-
tofluorescence. The following antibodies were used for
primary detection: chicken anti-GFP (1:200; Aves Labs,
Tigard, OR), rat anti-CD45 (1:500; Abcam, Cambridge,
United Kingdom), rat anti-F4/80 (1:200; Abcam), rabbit
anti-CD4 (1:300; Abcam), goat anti-arginase I (1:100;
Santa Cruz, Dallas, TX), rabbit anti-neurofilament-200
(1:200; Sigma), goat anti-myelin basic protein (MBP;
1:500; Santa Cruz), mouse anti-O4 (1:100; Millipore),
rabbit anti-Tuj1 (1:500; Sigma), and mouse anti-NeuN
(1:500; Millipore). Species-specific secondary antibodies
were used for detection at 1:1000 (Life Technologies,
Carlsbad, CA). Hoechst 33342 (Life Technologies) was
used as a counterstain in all tissue sections.
FIG. 1. Spinal progenitors can be cultured on PLG bridges. (A) A solution of EGFP+ spinal progenitor cells in a
fibrinogen-thrombin mix is pipetted onto bridges and the fibrin solution polymerizes at 37C before media are added. (B–D)
EGFP+ cells are cultured on the PLG bridges for 3 days to allow cells to disperse throughout the material, at which time the
presence of channels becomes visible (channel midline denoted by dashed lines) and small clusters of spheres (denoted by
*) have resolved onto the bridge. After 3 days of culture on bridges, there was no significant difference in cell number per
bridge (E) or the percentage of these cells that were viable (F), as assessed by flow cytometry. Further evaluation with flow
cytometry of the E14 cells on the bridges revealed that greater than 70% of the E14 cells on the bridges are Nestin+ (G), a
modest decrease compared to neurosphere cultures (n= 6 samples per condition, *p < 0.05). Nestin+OLIG2+ cells increase in
the bridges, but are not significantly different from E14 neurosphere cultures. (H) Total percent OLIG2+ cells are signif-
icantly increased in bridges compared to neurosphere cultures (n= 6 samples per condition, **p < 0.001). Data are re-
presented as mean – standard deviation. Scale bar= 200mm. PLG, poly(lactide-co-glycolide); E14, embryonic day 14;
EGFP, enhanced green fluorescent protein.
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Immunostained tissue sections were imaged using an Axio
Observer inverted fluorescence microscope (Zeiss) using a
10· dry objective. All quantification of EGFP+ cells, cell
phenotypes, or axon/myelin quantification was confined to the
bridge region. Bridge area exhibited some residual auto-
fluorescence due to the presence of the polymer with ran-
domized cellular distribution within channels and pores, while
contralateral tissue had even cellular distribution, although at
lower densities than the bridge. Based on these criteria, the
bridge area was defined conservatively to avoid inclusion of
tissue at the interface of the intact tissue and bridge.
Semiautomated counting software, previously described
by McCreedy et al.,66 was used to quantify axons and the
co-localization of myelin with axons in transverse sections
taken from the rostral, middle, and caudal regions of the
injury. Briefly, the software was calibrated using manual
NF-200+ and NF-200+MBP+ counts from a subset of
transverse images taken from different animals and regions
of the implant. The software then used a series of Hessian
filters and threshold functions within the bridge region to
reduce noise for selected NF-200 and MBP images.66 The
software then output total axon counts, as well as the my-
elinated axon counts based on the curvilinear MBP co-
localizing with axons. ImageJ (NIH, Bethesda, MD) was
used to analyze all other fluorescent images and define the
bridge area. The bridge was divided into these three seg-
ments to delineate between the rostral, middle, and caudal
regions of the bridge, as axons will grow from the rostral
and caudal ends into the bridge and will therefore have
higher densities than the middle of the bridge at 8 weeks.
Three tissues were used for each region (rostral, middle, and
caudal) of each animal. For 6-month tissue, there was no
difference between these three regions, and thus, the axon
densities were averaged across all regions within the bridge
resulting in nine tissues used for quantification.
For other cell phenotype markers, cells can enter the
bridge from the lateral and medial edges, and thus, this re-
gional distinction was unnecessary. EGFP+ cell survival was
quantified in two ways. In the first, the cells were quantified
and divided by the bridge area (region criteria described
above) for nine tissue sections per animal to determine cell
density. This value was for an 18 mm tissue section, which
was extrapolated across the 2.25mm bridge length to obtain
the cell number for the bridge volume. The cell number/
bridge volume was then divided by the number of cells
delivered on the bridge to arrive at the percent EGFP sur-
vival. Transplanted cells identified by EGFP+ cells as well
as mature neurons (NeuN) containing Hoechst+ nuclei were
counted manually by two blinded researchers indepen-
dently. Similarly, cells positive for CD45+ (leukocytes),
CD45+CD4+ (helper T cells), F4/80+ (macrophages), and
F4/80+arginaseI+ (M2 macrophages) containing Hoechst+
nuclei were also counted manually by two blinded re-
searchers to quantify infiltration of immune cells.
Basso Mouse scale
Basso Mouse scale (BMS) was used to evaluate mice in
an open-field locomotion test. Two researchers scored the
mice on ankle movement, hindlimb placement, hindlimb
stepping, and trunk stability and must reach a consensus to
ensure accuracy. Mice were acclimated to the open field
before testing and for the raters to become familiar with the
normal gait pattern of the mice. Mice were scored weekly
for the first month and then every other week for 6 months
after surgery.
Statistics
Multiple comparisons pairs were analyzed using a one-
way analysis of variance (ANOVA) with Tukey post-hoc
test. For all conditions, n= 6 mice per condition per time
point for histological analysis. BMS data were analyzed
using two methods. In the first, a one-way ANOVA with
repeated measures was used with a Tukey post-hoc text. In
the second, a chi-square test was used to evaluate the initial
binary ability of each mouse to perform hindlimb stepping
(BMS score 4) with data plotted as a contingency graph
indicating the percentage of the population that could hin-
dlimb step. For hindlimb stepping, n = 11 mice for each
condition. Significance was defined at a level of p< 0.05
unless otherwise noted. All data are reported as
mean – standard deviation.
Results
Development of an EGFP-spinal progenitor delivery
paradigm
Dissociated EGFP+ spinal progenitors from either E14 or
age-matched adult spinal cords were suspended in a fibrin-
ogen solution, mixed with thrombin, and pipetted onto
bridges. The fibrin gel was retained within the pores and
functioned to enhance the seeding efficiency (Fig. 1A). EGFP+
cell occupancy was evaluated over 3 days (Fig. 1B–D) to
ensure a well-distributed population before transplanting the
cell-laden bridges. There was no significant difference in
cell number or viability between the adult and E14 cells
after culture on the bridges in vitro as assessed by flow
cytometry (Fig. 1). We tested the maintenance of the E14
progenitor phenotype on bridges in comparison to neuro-
sphere colonies and demonstrated that greater than 70% of
the cells maintained a Nestin+ phenotype with an increase in
OLIG2+ cells in the bridges compared to neurosphere con-
trols (Fig. 1; Supplementary Fig. S1; Supplementary Data
are available online at www.liebertpub.com/tea).
EGFP-spinal progenitors exhibit source-dependent
survival
We subsequently investigated survival of the spinal pro-
genitors that were transplanted on bridges into a lateral T9–
10 hemisection spinal cord defect. Spinal progenitors from
two different sources were investigated, using E14 progen-
itors that were posited to enhance survival and regeneration
compared to age-matched (adult) progenitor controls that
likely exhibit limited survival and regenerative potential
comparable to the endogenous progenitor population. Cords
were collected 7 days postinjury and evaluated histologi-
cally for E14 EGFP+ cells (Fig. 2A) and age-matched adult
EGFP+ transplant control (Fig. 2B) survival. EGFP+ cells
were evident throughout the bridge on day 7, with cells along
both the lateral and midline edges of the bridge. The overall
survival of the transplanted cells was low for both conditions,
although a 3.9-fold increase in EGFP+ cell density (Fig. 2C,
p=0.0015, n= 6) and an increased percentage survival (Fig. 2D)
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were observed for E14 transplants (4.9%) compared to adult
transplants (2.6%). At 8 weeks, EGFP+ cell survival had
dropped to 0.3% (E14) and 0.17% (adult) of the initial
transplant population (Supplementary Fig. S2). Furthermore,
of the surviving cell population at week 8, 35% (E14) and
46% (adult) of the remaining cells had migrated into the
contralateral tissue (Supplementary Fig. S2). By 6 months,
only 0.42–2.1 EGFP+ cells/mm2 cells were observed across
both spinal progenitor conditions (data not shown).
Spinal progenitor-laden bridge transplants do not affect
leukocyte infiltration
Stem and progenitor populations have been implicated
in modulating the inflammatory response, and we subse-
quently investigated the host response to blank bridges or
cell-loaded (E14 or adult) bridges. No difference in CD45+
leukocytes (Fig. 3A; Supplementary Fig. S3) or CD45+CD4+
helper T cells (Fig. 3B; Supplementary Fig. S3) was detected in
the blank bridges or EGFP-spinal progenitor (E14 or adult)-
loaded bridges 7 days postinjury. Furthermore, themacrophage
density was not changed (Fig. 3D; Supplementary Fig. S4), nor
was the percentage of macrophages that were arginase I+
( p= 0.052, Fig. 3C; Supplementary Fig. S4).
E14 spinal progenitors enhance early axon elongation
through the injury
We next investigated the extent to which the severed as-
cending and descending axons elongate through the bridge from
the caudal or rostral ends of the injury. Axonswere identified by
neurofilament staining, and 0.18mm transverse sections were
FIG. 2. EGFP+ spinal progenitors
survive in the bridge 7 days post-
injury and implantation. EGFP+
spinal progenitor cells isolated
from (A) E14 or (B) adult spinal
cords survive postinjury inflamma-
tion. White lines delineate bridge
area, while rectangles denote
higher magnification insets for
Hoechst33342 and EGFP. In-
creased cell density (C) and percent
EGFP+ survival from the total cell
number implanted (D) of E14
EGFP+ spinal progenitors com-
pared to adult EGFP+ spinal pro-
genitors suggest improved survival
of E14 cell transplants (*p < 0.05,
**p < 0.005, n = 6 mice per bridge
condition), although the overall
percent survival is low. Data are
represented as mean – standard de-
viation. Scale bar = 200 or 20 mm
(inset).
FIG. 3. Immune cells infiltrate blank and spinal progenitor-
loaded bridges at 7 days postinjury. (A) Total CD45+ leukocyte
infiltration is not altered due to the presence of transplanted stem
cells. (B) The percentage of the total leukocyte population that
is CD45+CD4+ T cells is not significantly different between
conditions, even with the presence of exogenous spinal pro-
genitors. No significant difference in total macrophages (C) or
arginase+ (M2) macrophages (D) was detected in histological
sections. There was a trend toward increased M2 macrophages
in bridges loaded with E14 transplant condition; however, this
increase was not statistically significant (p= 0.8, n=6 mice per
bridge condition). Full immunohistochemistry of CD45 with
CD4 and F4/80 with arginase can be seen in Supplementary
Figures S3 and S4. Data are represented as mean – standard
deviation.
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separated into three 0.75mm segments of the bridge: rostral
(R), middle (M), and caudal (C), for tissue at 8 weeks (Fig. 4).
NF-200+ axons are present in all sections of bridge in each
condition. For blank bridges, axon regrowth appears confined to
the channels, whereas bridges transplanted with adult or E14
spinal progenitors had axon growth throughout the bridge cross-
section (Fig. 4A). Bridges transplanted with E14 spinal pro-
genitors had an increased axon number relative to blank and
adult spinal progenitor bridge controls, with the greatest in-
crease resulting primarily from axon numbers in the rostral and
caudal sections of the bridge (Fig. 4C). Therewas no observable
co-localization of EGFP and NF-200, suggesting that the
transplanted cells did not directly contribute to the increase in
axonal density within the bridge.
Axon elongation through the injury was evaluated at 6
months to discern if the difference in axon regrowth at 8
weeks was maintained. Regrowth was averaged through all
sections (rostral, middle, and caudal) of the bridge at 6
months, as no discernable location-based differences in axon
counts were observed. After 6 months, axon density in-
creased *10-fold compared to 8-week data, indicating ro-
bust axon regeneration is possible with PLG bridges. Axon
density within the bridge across all conditions was approx-
imately half of that observed in the tissue contralateral to the
bridge. The initial enhancement in axon numbers between
E14 cell-loaded bridges and the adult cell-loaded and empty
bridge controls observed at 8 weeks was not evident at 6
months. The high degree of axon regrowth suggests a sup-
portive regenerative environment is created using the bridge
alone, yet with more rapid regrowth evident upon inclusion
of E14 spinal progenitors (Fig. 4C).
E14 spinal progenitors improve myelination of axons
within the bridge
The extent of myelination of the regenerating axons was
subsequently characterized, which is necessary for functional
improvements.MBP+myelin,which does notmake a distinction
FIG. 4. Bridges loaded
with E14 EGFP+ spinal pro-
genitors enhance axon elon-
gation at 8 weeks after
transplantation in T9-10
hemisection. (A) Qualita-
tively, NF-200+ axon ex-
pression is greater in bridges
containing E14 EGFP+ spinal
progenitors compared to
adult EGFP+ spinal progeni-
tors and empty bridges. (B)
Quantification of regenerat-
ing axons was binned into
three 0.75mm transverse
sections of the bridge: R-
rostral, M-middle of the in-
jury, and C-caudal. (C) Axon
density is increased in E14
EGFP+ spinal progenitor-
loaded bridges compared to
adult EGFP+ spinal
progenitor-loaded and empty
bridges at 8 weeks post-
injury. This increase is most
dramatic in the rostral and
caudal sections of the
bridges. By 6 months, axon
density is similar for all
conditions. Data are re-
presented as mean – standard
deviation. n = 6 mice per
bridge condition, *p < 0.05,
**p < 0.01, ***p < 0.001.
Scale bar 200 mm.
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between cell source (oligodendrocytes or Schwann cells) or
myelin quality (compact vs. noncompact, internodal distance),
was found to co-localize with the regenerating axons in the
bridge (Fig. 5A). Myelinated axons were seen throughout the
progenitor-loaded bridges, localizing within channels and along
the midline of the tissue, while myelinated axons within the
blank bridges were predominantly found within channels. An
increase inmyelinatedaxondensity for bridges transplantedwith
E14 spinal progenitors compared to adult spinal progenitor and
blankbridgeswasobserved at 8weeks,with significant increases
observed in the rostral tissue yielding 4.8-fold and 3.5-foldmore
myelinated axons relative to adult and blank bridges, respec-
tively (Fig. 5B). The average percentmyelination throughout the
bridge for each condition was similar for each condition
(Fig. 5C), however, a trend toward increased myelination was
observed for E14 spinal progenitor loaded (31.6%) relative to
FIG. 5. Bridges loaded with E14 EGFP+ spinal progenitors enhance myelination of axons at 8 weeks after spinal cord
injury. (A) Qualitatively, myelination (MBP) of NF-200+ axon expression is greater in E14 bridges compared to adult
progenitor and empty bridges. Quantification of myelination was binned into three 0.75mm sections of the bridge: R-rostral,
M-middle of the injury, and C-caudal. Arrowheads indicate axons wrapped in myelin that traverse the tissue longitudinally.
Asterisks indicate myelinated axon cross-sections. Increased myelination (B), but not overall percent myelination (C), was
observed in E14 bridges compared to blank and adult progenitor bridges at 8 weeks. Differences in myelinated axon density
or percent were no longer evident 6 months postinjury. Data are represented as mean – standard deviation. n= 6 mice per
bridge condition, **p< 0.01, scale bar 10mm.
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adult spinal progenitor loaded (23.7%) and blank (27.1%)
bridges (p=0.13) at 8 weeks.
At 6 months, the density of myelinated axons increased
*10-fold across all conditions (Fig. 5B), eliminating the
initial difference seen in myelination at 8 weeks. No sig-
nificant difference was observed between myelination per-
centage at 8 weeks and 6 months; however, the average
percent of myelinated axons did trend higher in the spinal
cord at 6 months with 34–40% of all axons being myelinated
(Fig. 5C). By contrast, 45–58% of the intact contralateral
spinal cord tissue was myelinated at 6 months, which was
significantly higher for the injured tissue receiving blank
( p = 0.0028) and E14 transplants ( p = 0.0473), but not adult
transplant ( p = 0.0973) bridges.
E14 spinal progenitor-loaded bridges increase neural
bodies within the bridge
We have demonstrated that progenitor-loaded bridges
result in early differences in axon elongation through the
bridge, but it is unclear if some of these axons are a result of
newly formed neuronal cells. For this reason, we evaluated
the early neuronal marker Tuj1 and early oligodendrocyte
marker O4 at 8 weeks, which presumably arose from either
the endogenous or exogenous (EGFP+) progenitors. After 8
weeks, there was a significant increase in both Tuj1+ and
O4+ cells observed within both E14 and age-matched con-
trol transplants compared to the blank bridges (Supple-
mentary Fig. S5). Less than 5% of the differentiated cells
within the bridge co-expressed EGFP. Of the EGFP+ cells,
less than 40% of the cells exhibited Tuj1 or O4 markers,
either within (Supplementary Fig. S5C) or outside of
(Supplementary Fig. S5D) the bridge.
The mature neuronal marker NeuN localizes to nuclei of
cells committed to a neuron lineage and was used to further
evaluate neurons within the bridge at 6 months. NeuN+
neurons were evident in each of the bridge conditions, in-
cluding bridges that were not loaded with exogenous spinal
progenitors (Fig. 6A–C). A significant increase in NeuN+
neurons was observed in E14 progenitor-loaded bridges, with
densities exceeding 1000 NeuN+ cells/mm2 (Fig. 6D). Spar-
ingly few (0.42–2.1 cells/mm2) EGFP+ cells were observed
within the bridge or adjacent tissue of mice receiving spinal
progenitor transplants. Transplanted EGFP+ cells accounted
for 1.6%– 1.4% and 7.6%– 6.7% of the NeuN+ cells within
the bridges of E14 and adult cell transplants, respectively.
The high variability of the NeuN+EGFP+ population is likely
due to the low 6-month survival rate of the transplanted cells.
FIG. 6. Increased neural bodies are present within E14 loaded bridges after 6 months. (A) Blank, (B) E14 spinal
progenitor-loaded, and (C) adult spinal progenitor-loaded bridges 6 months after transplantation in a spinal cord hemi-
section stained for NeuN and EGFP+ cell transplants (>) with Hoechst nuclear counterstain. Quantification of histological
sections exhibits a significant increase in NeuN+ neurons in E14 spinal progenitor-loaded bridges (D). Data are represented
as mean – standard deviation. n= 6 mice per bridge condition, *p< 0.01, scale bar 20mm.
FIG. 7. Faster ability of hindlimb stepping through inclusion of E14 spinal progenitor cells. Average BMS scores are
observed to increase over time for each condition; however, no significant difference between groups over time was
observed as determined by one-way analysis of variance with repeated measures using a Tukey post-hoc test (A). By 8
weeks, significantly more mice that received bridges with E14 transplants were able to perform stepping (BMS = 4) on
ipsilateral hindlimb affected by the lateral hemisection as determined by chi-squared test [(B); *p < 0.01, n= 11 mice per
bridge condition]. By 6 months, 90% of mice receiving either E14 or adult transplants achieved stepping compared to 70%
transplanted with blank bridges. ANOVA, analysis of variance; BMS, Basso Mouse scale.
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Together these data suggest that the E14 spinal progenitor
cells support robust infiltration of endogenous progenitor
cells, leading to new neurons within the bridge that likely
arises from both exogenous and endogenous progenitor
populations. Moreover, the EGFP+NeuN+ cells within bridges
receiving the age-matched transplants exhibit newly formed
neurons, demonstrating that adult spinal progenitors may in-
deed be capable of neuronal differentiation, but to a lesser
extent than the younger progenitor populations.
Modest improvements in locomotion present in mice
with no difference in long-term regrowth
An open field locomotor BMS test was performed to assess
coordination and hindlimb motor function. Average BMS
scores were observed to increase across all conditions over
time (Fig. 7A). With 90% of the mice that received E14 spinal
progenitor-loaded bridges recovering hindlimb stepping abil-
ities by 8 weeks postinjury, these mice demonstrated a sig-
nificantly (Fig. 7B, p< 0.01) earlier recovery compared to
adult spinal progenitor-loaded or blank bridges. Ninety percent
ofmice receiving adult spinal progenitors were able to perform
hindlimb stepping by week 18, whereas only 73% of mice
receiving blank bridges achieved stepping by 6 months.
Discussion
In this work, we provided a conservative estimation of
exogenous spinal progenitor cell survival from bridges, re-
sulting in a modest increase in transplanted EGFP+ cell
survival (4.9%) at the injury epicenter compared to the 0.5–
2% reported in the literature.26,34–36 Exogenous stem and
progenitor cells have the potential to repopulate an injury
through expansion, and can also promote the recruitment of
endogenous progenitor populations. The benefits of exoge-
nous cells, whether multipotent NSCs or more differentiated
progenitor cells, are contingent upon their ability to survive
the highly inflammatory microenvironment at the injury. In
this work, E14 spinal progenitors were able to survive
transplantation following SCI and a subset of the population
migrated into the intact contralateral tissue. Survival of
spinal progenitor cells at 1 week was*5% of the initial cells
seeded on the bridge and less than 1% after 8 weeks; however,
these numbers may underestimate cell density due to potential
silencing of the EGFP gene. Butenscho¨n et al. reported inad-
equate EGFP expression for detection due to silencing of
EGFP by 5 weeks after transplantation of progenitors and used
BrdU labeling as an alternative method to quantify the pro-
genitors within the injury.37 They found that 4% of the cells
co-expressed BrdU and markers for neuronal lineages, but did
not delineate between exogenous and infiltrating endogenous
progenitors. Nevertheless, proliferative markers may be poor
indicators of exogenous cell transplants, as proliferation has
been shown to be limited to the first few weeks after trans-
plantation.67 While EGFP expression may be silenced over
time, quantification by EGFP provides a conservative assess-
ment of survival of exogenous cells for our studies compared
to the use of proliferative markers.
The level of engraftment for spinal progenitors within the
bridge is consistent with the upper limits reported by others
that have transplanted neural stem or progenitor cells iso-
lated from either the brain or spinal cord into an injured
spinal cord without immunosuppression. Studies delivering
progenitor cells within a hydrogel without immunosup-
pression in mice have previously seen only 1.2% cell sur-
vival 1 week after transplant.35 Similarly, cell survival
following direct injection methods without immunosup-
pression in immune-competent animals results in poor sur-
vival (0.5–2%) when characterized by histology.34,36,37
Utilizing a NOD-SCID model of SCI to evaluate spinal
progenitor transplant survival after direct injection increased
survival to *10–20% after 1 week,67,68 with no further
therapeutic advantage in co-delivery of immunosuppres-
sants in the NOD-SCID model.69 Reported differences in
survival may be attributed to the delivery and quantification
methods across these studies. For example, quantification of
survival using bioluminescence imaging tends to obtain
higher cell densities up to 10%33 compared to flow cytom-
etry or histology. Regardless of these methods, it is likely
that survival is limited without active control of inflamma-
tion. PLG bridges have been shown to attenuate inflamma-
tion by limiting glial scar formation and immune cell
infiltration compared to no treatment injured controls, yet do
not shift the phenotype toward anti-inflammatory.46,60 De-
livery of interleukin-10 from the bridges produced a more
regenerative microenvironment even in the presence of
immune cells due to the shift toward anti-inflammatory
immune phenotypes.65 The delivery of immunomodulatory
factors that limit inflammation may have the potential to
further enhance cell transplant survival when delivered
within bridges as a localized strategy, rather than systemic
immunosuppression.
In this work, bridge-mediated delivery of E14 derived spinal
progenitor cells attained greater survival relative to the age-
matched adult spinal progenitors. Survival of transplanted
cells in an SCI model has been reported to be dependent on
injection dose,26,41 location,26,40 and cell source.26,70 Optimal
injection dosages of 104–105 cells/animal are preferable as
increasing the dosage has a negative impact on survival and
proliferation of the transplanted cells.41 Injections of these
cells into the rostral and caudal tissue rather than the injury
epicenter will also increase cell survival twofold and allow the
cells to migrate into the injury over time as inflammation
dissipates.40
The largest source of survival variability can be attributed
to the cell source, such as species, tissue location, and host
age.26 Immature stem cells express fewer major antigens
than terminally differentiated cells,59,71,72 a characteristic
that is increasingly prominent with stem cells sourced from
embryonic tissue,38 such as the E14 spinal progenitors when
compared to adult spinal progenitors. Interestingly, no sig-
nificant differences in infiltration of the immune cell phe-
notypes evaluated within spinal progenitor-loaded bridges
were observed compared to blank bridges. One possible
explanation for this result is that enhanced survival of E14
spinal progenitors was due to decreased susceptibility to
apoptosis through increased activation of proliferation and
survival pathways in the inflammatory milieu compared to
adult spinal progenitors.73 However, the degree of survival
was likely insufficient to further modulate infiltrating im-
mune phenotypes to the extent observed in vitro, where
there is a more robust ratio of progenitor cells to immune
cells.9–11
E14 spinal progenitor cells exhibit increased survival
compared to the adult spinal progenitor cells, suggesting
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that they may also make larger contributions to the bio-
chemical milieu. Neural stem and progenitor cells secrete
numerous neurotrophic and immunomodulatory factors, a
subset of which mediates endogenous progenitor recruit-
ment. Neural stem and progenitor cells have been reported
to express extracellular matrix constituents, such as glyco-
proteins and12–16 proteoglycans.13,15,17–22 These cells can
also produce endogenous neurotrophins6–8,23–25 immuno-
modulatory cytokines.9–11,21,25 Furthermore, cell-cell adhe-
sion molecules9,14 are upregulated by progenitor populations
when transplanted into an injury and may foster more at-
tachment sites for growing axons. A number of these factors
have only been demonstrated with in vitro release by neural
progenitor cells6–8,12–15,17–25 or in co-cultures with immune
cells,9–11 while in vivo release of these factors has been
attributed to progenitor transplants, but has not been directly
demonstrated.6,12,16,17,23
Transplantation of spinal progenitors into a CNS injury
resulting in increased concentrations of neurotrophic or
immunomodulatory factors compared to the injury alone
suggests that transplanted cells may release these factors or
encourage other cells to release these factors to promote
regeneration, as few spinal progenitors survive after trans-
plant. The proteins secreted by the adult and E14 sourced
progenitor cells may be variable in composition and con-
centration due to inherent differences in the cell pheno-
types.73–77 These differences would be pronounced
immediately after bridge implantation, as the transplanted
cells were cultured for 3 days on the bridges before im-
planting, thus allowing the spinal progenitor cells to deposit
numerous factors onto the bridges. Potential differences in
the biochemical milieu of adult and E14 cells would likely
continue due to differences in survival rates, with greater
expression of survival genes in cells sourced from younger
tissues,73 thus allowing more cells to make biochemical
contributions to the injury microenvironment.
Potential differences in the biochemical milieu may
contribute to observed increases in axon elongation and
myelination at 8 weeks. Delivery of E14 spinal progenitors
promotes faster axon regrowth and myelination than adult
spinal progenitors or bridges alone. The initial increase in
regrowth may also be indicative of increased plasticity
outside of the bridge that contributed to the observed ability
for 90% of the mice to perform stepping earlier in E14
progenitor-loaded bridges. The ability of mice in the other
two groups eventually develops a similarly large percent
(70–90%) of the population that can achieve stepping at 6
months and this corresponds to a commensurate increase in
axon regrowth through the bridge. Quantification of axon
density in the contralateral tissue demonstrated no differ-
ence between conditions at 6 months (data not shown).
Axon density within the bridge was approximately half the
density of axons within the contralateral tissue at 6 months,
suggesting robust regrowth through the bridge in all con-
ditions that may mask the early benefits to axon regrowth as
a result of transplanting E14 spinal progenitors.
Robust axon regeneration observed in this study had not
previously been observed between 9 weeks and 6 months
postinjury within a rat model46 and may be due to the
combination of fewer channels in the bridge, decreased
porosity, and quantification of axons being limited to the
channels within the rat bridges compared to the mouse
bridges. While the robust axon growth is promising, future
studies will investigate strategies to increase E14 spinal
progenitor survival through the use of delayed delivery
methods and co-administration of localized anti-
inflammatory factors. Increased survival will likely lead to
enhanced biochemical contributions and subsequent regen-
eration and this will be increasingly evident at later time
points when the E14 cells no longer offer an advantage to
axon regrowth.
Interestingly, the 10-fold increase in axon density within
the bridge at 6 months, which approached contralateral axon
density, did not correlate to significantly higher average
BMS scores over time, suggesting that the axons may not
have formed or may have incorrectly formed synapses with
intact tissue, and thus did not contribute to enhanced step-
ping abilities, such as hindlimb coordination and trunk sta-
bility. Retrograde tracing techniques would be necessary to
discern whether synapses are forming between axons
growing through the bridge with intact motor circuitry or
whether the improved recovery is due to increased sparing
of axons outside of the bridge. Ultimately, axon regrowth is
necessary to rebuild circuits; however, limited data have
shown a direct correlation between improved BMS and axon
density following SCI due to limited in vivo imaging tech-
niques for axon density over time. A positive correlation of
spared axon area with locomotor function recovery using
diffusion tensor imaging has been made at the individual
animal level; however, this correlation was not extended to
axon density.78
We report that roughly 30% of the axons are myelinated
across all conditions and previous reports state that 40–60%
of spinal cord axons are myelinated in healthy rodents,79,80
yet this relatively high density of axons did not correlate
with an improved locomotor recovery. The average BMS
score did not significantly improve after week 8 even with
substantial axon growth and 40% myelination at 6 months.
As discussed previously, a number of factors would explain
the lack of correlation between histological improvements
and behavioral improvements. Not only is the axon regrowth
and correct synapse formation necessary but also myelina-
tion of these axons will play a role in restoration of motor
function. It is possible that the myelin quality may be in-
ferior, thus requiring higher levels of myelination within the
expected healthy range79,80 to achieve higher functional
benefits. Furthermore, myelination was not quantified in
continuous transverse tissue sections; thus, axons may not
be myelinated along their full length, which could also
contribute to reduced functional recovery relative to the
report myelinated axon density.
Appreciable differences in the density of neural cell
bodies within the bridges at 8 weeks and 6 months were
observed, despite the modest survival of the exogenous
progenitors. Neurogenesis following SCI has been reported
previously with both exogenous26,32,63,81 and endoge-
nous29,30 progenitors. Both native and transplanted progen-
itors that give rise to new neurons have the potential to
integrate onto preexisting circuits, forming functional syn-
apses, as demonstrated by electrophysiology30,63 or mono-
synaptic rabies tracing.82 By 6 months, neurons were
evident in all bridge conditions, even those devoid of initial
cellular transplants, suggesting a basal level of neurogenesis
by local progenitors that migrate into the bridges, although
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there is little evidence in the literature that endogenous
progenitors in the spinal cord are capable of neurogen-
esis.29,30 An increase in neural body density was observed
within the E14 spinal progenitor-loaded bridges, with few of
these NeuN+ cells co-expressing EGFP+. NeuN+EGFP+
neurons originating from exogenous cells were also ob-
served with the adult transplants, although to a lesser extent
than that observed with the E14 transplants.
The presence of EGFP+NeuN+ cells within adult
transplants suggests that the adult spinal cord progenitors
are capable of neurogenesis; however, it is significantly
reduced compared to prenatal spinal progenitors. While
the remaining neurons within the bridge were not EGFP+,
it is possible that the EGFP was silenced and that exog-
enous cells are indeed contributing to the increased
NeuN+ cell density. However, it is also likely that these
newly formed neurons are originating from endogenous
cell populations given that NeuN+ cells were observed in
the blank bridges. It is unlikely that mature neurons mi-
grated into these bridges, as primarily progenitors and
neuroblasts are thought to be capable of migration within
the adult CNS.83 However, interneurons within the hip-
pocampus can migrate short distances and maintain their
synaptic connections.84 Additional studies would be
necessary to determine the source of these cells, and the
critical assessment of neural phenotype and electrophys-
iology would be required to discern if these cells have
integrated into host circuitry.
Conclusion
In summary, we investigated the transplantation of E14
spinal progenitors on multichannel PLG bridges with the
goal of enhancing the number and extent of myelination for
axons growing into and through the injury. We successfully
delivered a modest spinal progenitor population and sur-
viving cells were correlated with a commensurate increase
in the density of axons and myelin at 8 weeks within the
injury for mice receiving E14 transplants compared to age-
matched adult transplants. This early regrowth of axons and
their myelination were correlated with a more rapid func-
tional recovery relative to the control conditions, although
by 6 months, the axon density and extent of myelination
were similar between all conditions as was the functional
recovery This work uses aligned bridges to deliver stem
cells and, in the future, can be combined with other thera-
peutics, such as the delivery of anti-inflammatory cytokines,
to further enhance transplant engraftment along with nerve
plasticity and repair.
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